| Nov 18 |
RFK Jr.'s HHS nomination sparks concern over pharma stocks
|
| Nov 18 |
Lilly heart drug muvalaplin significantly reduces lipoprotein(a) levels
|
| Nov 18 |
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high risk for cardiovascular events by up to 85% at highest tested dose
|
| Nov 18 |
Novo Nordisk reportedly launches Wegovy in China
|
| Nov 18 |
How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
|
| Nov 18 |
Lilly, Incyclix to work on Verzenio combo treatment for breast cancer
|
| Nov 18 |
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
|
| Nov 18 |
Market Chatter: Eli Lilly, Novo Nordisk Obesity Drugs Covered Mostly by Medicaid, Analysts Say
|
| Nov 18 |
Eli Lilly’s tirzepatide cuts risk of worsening heart failure in HFpEF, obese patients
|
| Nov 18 |
Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
|
